Navigation Links
Could fungal collection hold the key to new life-saving drugs?

Scientists may be one step closer to finding new drugs to fight MRSA, cancers and other diseases, after CABI, a leading bioservices organisation announced that its fungal collection will be screened by the University of Strathclyde.

CABI houses one of the world’s largest genetic resource collections of fungi, numbered at over 28,000 strains, including Fleming’s original penicillin producing isolate. They will be supplying the University of Strathclyde’s Institute for Drug Research (SIDR) with extracts from filamentous fungi which will be screened to identify pharmaceutically active compounds, which could potentially be developed into drugs.

Joan Kelley, Executive Director Bioservices, CABI said:

“This is a really exciting collaboration and we are looking forward to working with the expertise of the scientists at SIDR. We are hopeful that our partnership will prove the winning formula for discovering new pharmaceutical drugs to fight cancers, diseases and resistant strains of infections such as MRSA.”

SIDR brings together scientists from different disciplines to focus on drug discovery. They have developed test systems to detect biological activity in samples of natural products that could lead to new medicinal products. Previous work at SIDR found activities from plant extracts against diabetes, obesity and psoriasis.

Professor Alan Harvey, Director of SIDR said:

“We are delighted to be working with CABI and to have access to their fantastic source of fungal samples. We hope that this novel source of chemical diversity will contain new compounds that can be used to point the way to new drugs for serious diseases.”

CABI currently uses its fungal collection, along with the expertise of its scientists to offer a range of services to businesses, including fungal identification, sales, preservations, patenting, training and consultancy. The partnership with SIDR will see CABI’s collection taken one
'"/>

Source:CABI


Page: 1 2

Related biology news :

1. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
2. Spider Venom Could Yield Eco-Friendly Insecticides
3. New Breast Cancer Test Could Save Lives
4. Discovery Could Lead To Novel Approaches In HIV Treatment
5. New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal
6. Protein Discovery Could Unlock The Secret To Better TB Treatment
7. Could microbes solve Russias chemical weapons conundrum?
8. Natural Killers Could Lead to New Hepatitis Treatments
9. Could better mangrove habitats have spared lives in the 2004 tsunami?
10. Cant serve an ace? Could be muscle fatigue
11. Transplanting Animal Organs Could Soon Be A Reality

Post Your Comments:
(Date:11/25/2009)....Scientists at the California Institute of Technol...ve emotion-like behavior in the fruit fly, Drosop...be relevant to the relationship between the neurot...ivity disorder (ADHD), are described in the Decemb...ila brain contains only about 20,000 neurons and ...
(Date:11/25/2009)...VEMBER 25, 2009 Soil is the linchpin of the envir...re meet. Despite that, many students see soil as "...re. Soil science educators are challenged with the... the critical importance of soil in the environmen...d earth science teachers at University of Nebraska...
(Date:11/24/2009)...rch Institute (LRI) today named 12 new grant recip... recognize innovative work across a broad spectrum...eativity, novelty, and potential to drive scientif...e the complex disease of systemic lupus. , The 2...searchers across the nation and include interdisci...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3NEW Momentum 28TM 29 Physician and Staff Scheduling Software for Imaging Centers OB GYN and Other Specialty Practices Improves Productivity and Equi 13024 1NEW Momentum 28TM 29 Physician and Staff Scheduling Software for Imaging Centers OB GYN and Other Specialty Practices Improves Productivity and Equi 13024 2Environmental Tectonics Corporation Announces Sale of Additional Monoplace Hyperbaric Chambers 13022 1Environmental Tectonics Corporation Announces Sale of Additional Monoplace Hyperbaric Chambers 13022 2Environmental Tectonics Corporation Announces Sale of Additional Monoplace Hyperbaric Chambers 13022 3Environmental Tectonics Corporation Announces Sale of Additional Monoplace Hyperbaric Chambers 13022 4Was SIDS the cause of infant deaths even 150 years ago 3F 51625 1
... / - Cambridge Healthtech Institute’s Fifth ...7-29, 2009 at the Loews Philadelphia Hotel, Philad...dline for this event is April 10, 2009. , The sign...omarker Series, The Biomarker World Congress 2009 ... all areas of biomarker research spanning the phar...
...t ethnic groups store fat in their bodies may acco...lop insulin resistance and non-alcoholic fatty liv... Center have found. , According to research repo... Hepatology, African-Americans with insulin resis...this form of metabolic liver disease. , Despite s...
... Institute has obtained the first glimpse of a pro... drugs, out of cells. The protein, called P-glycop...ns cancer cells are resistant to chemotherapy drug... design more effective drugs. , The new research ...journal Science . , "This structure is an impor...
Other Biology News:CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 2CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 3CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 4CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 5Difference in fat storage may explain lower rate of liver disease in African-Americans 2Difference in fat storage may explain lower rate of liver disease in African-Americans 3Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 2Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 3
(Date:11/25/2009)... Ambassador to Speak at Economic Cl...anada (Vocus) November 25, 2009 -- Ambassador to S...vid Appia, French Ambassador for International Inv...nce Agency ,To view a biography of David Appia go ...or Appia is available to meet with press to discus...
(Date:11/25/2009)...NDIEGO,Nov.25/PRNewswire-FirstCall/--ArdeaBioscien...art,Pharm.D.,presidentandchiefexecutiveofficer,wil...rence. , ,Presentationdetailsareasfollows:,Piper...,December1,2009,Time:2:00p.m.EasternTime,Location:...ttp://www.corporate-ir.net/ireye/,target=,_blank,...
(Date:11/24/2009)...NTACRUZ,Calif.,Nov.24/PRNewswire/--Twomoreprestigi...,sleadingonlinejobboardandcareerssiteforlifescienc...rsityarenowmembersofthejobboard,joining28othermajo...d, www.biocareercenter.com ,isonlyforpost-graduate...ncecareersitesontheInternet,BioCareerCenteristheon...
(Date:11/24/2009)...YKJAVIK,Iceland,November24/PRNewswire-FirstCall/--...heapprovalofallofits,"firstday"motionsbytheU.S.Ban...cyCourt").deCODElastweekfiledavoluntarypetitionfor...dewiththe,BankruptcyCourt. , Theordersissuedb...rateitsbusinessduringtheChapter11proceedings.Inpar...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...to serve Pacific Northwest, SEATTLE, Dec. 21 Ste... the western Washington state congressional delega...ng designated to help development,of a state-of-th...ncer Care,Alliance (SCCA). The money is included i...resident Bush on Thursday, Dec. 20., "The leaders...
...rmaceuticals, Inc. (Nasdaq: LXRX ) announced toda...g (IND) application to the U.S. Food and Drug,Admi...e for managing,gastrointestinal symptoms associate...nical trial of LX1032 is planned as a double-blind...dose study in healthy volunteers. This,study is de...
..., Conn., Dec. 20 /PRNewswire-,FirstCall/ -- Cell G...affiliate of GBP Capital, the majority shareholder...ounced that the two companies have entered,into an...ntiviral gene,delivery technology, commonly referr...ment, Cell Genesys has received a payment of $12 m...
Other Biology Technology:Murray Leads Delegation in Securing $2.1 Million for Proton Therapy Center 2Murray Leads Delegation in Securing $2.1 Million for Proton Therapy Center 3Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 2Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 3Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million 2Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million 3Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million 4Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million 5
Mouse Anti-Human FBXO11 Monoclonal Antibody, Unconjugated, Clone 4C12 from Abnova Corporation
Mouse Anti-Human LASS3 Polyclonal Antibody, Unconjugated from Abnova Corporation
Rabbit Anti-Nonmuscle Myosin II Heavy Chain B (MHC-B) Polyclonal Antibody, Unconjugated from Covance Research Products, Inc
Rabbit Anti-Mi-2 Polyclonal Antibody, Unconjugated from Upstate
Biology Products: